Endocrine Status of MG Stroma Alters Breast CA Invasion

MG 基质的内分泌状态改变乳腺 CA 侵袭

基本信息

  • 批准号:
    7287605
  • 负责人:
  • 金额:
    $ 5.83万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-06-04 至 2006-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The relationship between reproductive history and breast cancer is complex. A full term pregnancy in younger women is protective against breast cancer later in life, while a first full term pregnancy after 40 years of age is associated with higher cancer occurrence. In addition, there is an increase in breast cancer within the first two years of pregnancy, regardless of age. Pregnancy associated breast cancer also presents at a later clinical stage and is more invasive than non-pregnancy associated breast cancers. We hypothesize that the cancer promotional effect of pregnancy is due to physiologic remodeling of the mammary stroma that occurs after pregnancy. During parturition or weaning-induced mammary gland involution, mammary stroma is degraded and stroma levels of matrix metalloproteinases (MMP) and pro-inflammatory mediators are elevated. We propose that these involution-associated changes in mammary stroma promote an epithelial to mesenchymal transition (EMT) in pre-existing neoplastic cells. The resulting activated tumor cells, coupled with the weakened stromal barrier, increases the likelihood of tumor cell extravasation. Since the likelihood of having occult tumor cells increases with age, pregnancy associated gland involution is more likely to effect EMT and metastases in older women. In Aim 1. the hypothesis that tumor cell metastatic potential is modulated by reproductive status will be tested in vivo using xenograft models. Human mammary tumor cells will be injected directly into teats or mammary fat pads of immunodeficient mice at different reproductive stages (i.e. nulliparous, 'pregnancy-associated', and parous). The ability of tumor cells to exit the gland is predicted to be dependent on the degree of tissue remodeling at the time of injection: low in nulliparous and parous, and high in regressing glands. Primary tumors will be evaluated histologically and metastases to lung, liver, brain and long bone of the leg will be measured by semi-quantitative PCR using a unique human sequence, the CCR5 gene. In Aim 2, the hypothesis that endocrine-induced changes in stroma composition can either promote or suppress EMT will be evaluated in vitro using reconstitution models. Human mammary epithelial cells, which differ in metastatic potential from non-tumorigenic to metastatic, will be combined with mammary stroma isolated from rats with different reproductive states. It is anticipated that quiescent mammary stroma (nulliparous and parous) will inhibit, while involuting matrix will promote EMT in highly metastatic cells. Functional evidence for EMT will be obtained by measuring stroma-dependent changes in cell adhesion, motility and invasiveness using modified Boyden chambers assays. Morphological and biochemical evidence for EMT will be evaluated in a 3-dimensional model of tumor formation. The effects of mammary matrix on key markers of EMT, actin fiber organization, and expression of E-cadherin, vimentin, gelsolin and Fspl proteins, will be determined biochemically. In Aim 3, the hypothesis that involuting mammary matrix induces, while nulliparous and parous mammary matrices suppress expression of MMP in tumor cells will be evaluated by reporter gene assays. Luciferase-based reporter constructs containing either the stromelysin (MMP-3), gelatinase A (MMP-2), or gelatinase B (MMP-9) promoters will be tested for activity in tumor cells plated on different mammary matrices. The results of these studies will contribute to our understanding of the effects pregnancy-associated changes in mammary stroma have on breast cancer progression, and should provide insights into epidemiological data describing the dual effect of pregnancy on breast cancer.
说明(由申请人提供):生育关系

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Pregnancy and weaning regulate human maternal liver size and function.
Multistep tumorigenesis and the microenvironment.
  • DOI:
    10.1186/bcr772
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Schedin P;Elias A
  • 通讯作者:
    Elias A
Developmental windows of breast cancer risk provide opportunities for targeted chemoprevention.
  • DOI:
    10.1016/j.yexcr.2013.04.018
  • 发表时间:
    2013-07-01
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Martinson, Holly A.;Lyons, Traci R.;Giles, Erin D.;Borges, Virginia F.;Schedin, Pepper
  • 通讯作者:
    Schedin, Pepper
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Pepper J Schedin其他文献

Pepper J Schedin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Pepper J Schedin', 18)}}的其他基金

NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention
产后复健期间使用非甾体抗炎药进行乳腺癌化学预防
  • 批准号:
    10113546
  • 财政年份:
    2013
  • 资助金额:
    $ 5.83万
  • 项目类别:
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention
产后复健期间使用非甾体抗炎药进行乳腺癌化学预防
  • 批准号:
    10372923
  • 财政年份:
    2013
  • 资助金额:
    $ 5.83万
  • 项目类别:
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention
产后复健期间使用非甾体抗炎药进行乳腺癌化学预防
  • 批准号:
    10588231
  • 财政年份:
    2013
  • 资助金额:
    $ 5.83万
  • 项目类别:
Endocrine Status of MG Stroma Alters Breast CA Invasion
MG 基质的内分泌状态改变乳腺 CA 侵袭
  • 批准号:
    6514478
  • 财政年份:
    2001
  • 资助金额:
    $ 5.83万
  • 项目类别:
Endocrine Status of MG Stroma Alters Breast CA Invasion
MG 基质的内分泌状态改变乳腺 CA 侵袭
  • 批准号:
    6752376
  • 财政年份:
    2001
  • 资助金额:
    $ 5.83万
  • 项目类别:
Endocrine Status of MG Stroma Alters Breast CA Invasion
MG 基质的内分泌状态改变乳腺 CA 侵袭
  • 批准号:
    6399858
  • 财政年份:
    2001
  • 资助金额:
    $ 5.83万
  • 项目类别:
Endocrine Status of MG Stroma Alters Breast CA Invasion
MG 基质的内分泌状态改变乳腺 CA 侵袭
  • 批准号:
    6633698
  • 财政年份:
    2001
  • 资助金额:
    $ 5.83万
  • 项目类别:
ECM MEDIATORS OF CHEMOPREVENTIVE AGENTS IN THE BREAST
乳房化学预防剂的 ECM 介质
  • 批准号:
    2429908
  • 财政年份:
    1996
  • 资助金额:
    $ 5.83万
  • 项目类别:
ECM MEDIATORS OF CHEMOPREVENTIVE AGENTS IN THE BREAST
乳房化学预防剂的 ECM 介质
  • 批准号:
    2114691
  • 财政年份:
    1996
  • 资助金额:
    $ 5.83万
  • 项目类别:
ECM MEDIATORS OF CHEMOPREVENTIVE AGENTS IN THE BREAST
乳房化学预防剂的 ECM 介质
  • 批准号:
    2895550
  • 财政年份:
    1996
  • 资助金额:
    $ 5.83万
  • 项目类别:

相似海外基金

A novel motility system driven by two classes of bacterial actins MreB
由两类细菌肌动蛋白 MreB 驱动的新型运动系统
  • 批准号:
    22KJ2613
  • 财政年份:
    2023
  • 资助金额:
    $ 5.83万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
EGF Receptor Endocytosis: Mechanisms and Role in Signaling
EGF 受体内吞作用:机制及其在信号传导中的作用
  • 批准号:
    10552100
  • 财政年份:
    2023
  • 资助金额:
    $ 5.83万
  • 项目类别:
Mitochondrial positioning regulates redox-signaling during cell migration
线粒体定位调节细胞迁移过程中的氧化还原信号
  • 批准号:
    10520211
  • 财政年份:
    2023
  • 资助金额:
    $ 5.83万
  • 项目类别:
ROS Signaling in Wound Healing vs Tissue Repair
伤口愈合与组织修复中的 ROS 信号传导
  • 批准号:
    10654242
  • 财政年份:
    2023
  • 资助金额:
    $ 5.83万
  • 项目类别:
Pyroptotic Macrophages Traps Against Shigella Infection
焦亡巨噬细胞捕获志贺氏菌感染
  • 批准号:
    10646015
  • 财政年份:
    2023
  • 资助金额:
    $ 5.83万
  • 项目类别:
Converting cytoskeletal forces into biochemical signals
将细胞骨架力转化为生化信号
  • 批准号:
    10655891
  • 财政年份:
    2023
  • 资助金额:
    $ 5.83万
  • 项目类别:
Differential changes in energy metabolism in response to mechanical tension give rise to human scaring heterogeneity
响应机械张力的能量代谢的差异变化导致人类恐惧异质性
  • 批准号:
    10660416
  • 财政年份:
    2023
  • 资助金额:
    $ 5.83万
  • 项目类别:
Engineered tissue arrays to streamline deimmunized DMD gene therapy vectors
工程组织阵列可简化去免疫 DMD 基因治疗载体
  • 批准号:
    10724882
  • 财政年份:
    2023
  • 资助金额:
    $ 5.83万
  • 项目类别:
Basis and Function of Lateral Assembly of Cadherin Molecules in Adhesive Junctions of Humans and Model Organisms
人类和模型生物粘附连接中钙粘蛋白分子横向组装的基础和功能
  • 批准号:
    10715056
  • 财政年份:
    2023
  • 资助金额:
    $ 5.83万
  • 项目类别:
HIV particle morphology and biogenesis
HIV颗粒形态和生物发生
  • 批准号:
    10772748
  • 财政年份:
    2023
  • 资助金额:
    $ 5.83万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了